Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults-Reference-Cited by-同舟云学术

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Published:2011-09-10 Issue:14 Volume:25 Page:1737-1745
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Min Sherene,Sloan Louis,DeJesus Edwin,Hawkins Trevor,McCurdy Lewis,Song Ivy,Stroder Richard,Chen Shuguang,Underwood Mark,Fujiwara Tamio,Piscitelli Stephen,Lalezari Jay

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference7 articles.

1. Understanding and managing the adverse effects of antiretroviral therapy.;Hawkins;Antiviral Res,2010

2. A new look at the statistical model identification.;Akaike;IEEE Trans Automat Contr,1974

3. Resistance and cross-resistance to first generation integrase inhibitors: insights from a Phase II study of elvitegravir (GS-9137).;McColl;Antivir Ther,2007

4. Short-term antiviral activity of TMC278 - a novel NNRTI - in treatment-naive HIV-1-infected subjects.;Goebel;AIDS,2006

5. A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjects.;Gruzdev;AIDS,2003

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

2. Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial;Journal of the Pediatric Infectious Diseases Society;2024-07-27

3. Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics;Clinical Pharmacology & Therapeutics;2024-07-16

4. Population Pharmacokinetic Analysis of Dolutegravir in Treatment‐Experienced Adults Living with HIV‐1;The Journal of Clinical Pharmacology;2024-07-16

5. Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis;AIDS Research and Therapy;2024-05-21